[248 Pages Report] As per Future Market Insight’s latest published report, the global Next Generation Optical Biometry Devices Market was valued at USD 320.7 Million in 2021.
Attribute | Details |
---|---|
Next Generation Optical Biometry Devices Market Size (2021) | USD 320.7 Million |
Sales Forecast for Next Generation Optical Biometry Devices (2028) | USD 461.3 Million |
Global Market Growth (2022 to 2028) | 5.4% CAGR |
Market Share of Top 5 Next Generation Optical Biometry Device Manufacturers | 60% |
Sales of next generation optical biometry devices are slated to rise at a CAGR of 5.4% to reach USD 461.3 Million by 2028.
In 2021, next generation optical biometry device shipments represented 16.1% share of the global ophthalmic imaging devices market. Hospitals account for 41.8% revenue share of the next generation optical biometry devices
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Particulars | Details |
---|---|
H1, 2021 | 5.11% |
H1, 2022 Projected | 5.36% |
H1, 2022 Outlook | 4.76% |
BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 60 ↓ |
BPS Change - H1, 2022 (O) - H1, 2021 | (-) 35 ↓ |
According to Future Market Insights analysis, the global next generation optical biometry devices market expects to drop by 35 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 projected value, the market during H1-2022 outlook period will show a dip of 60 BPS.
Major factors attributed to this dip includes lack of trained professionals, and a high cost of optical biometry devices which is set to provide a restrictive impact upon the market growth through the forecasted years.
Moreover, advances in product design and integration of digitalized solutions together with product adoption scenario may be impacted with the cost constraints of initial equipment setting up, as well as the gradual maintenance and upgrade costs to follow.
Following several restrictive scenarios, the market has observed a change in the BPS values, and thus will be likely to experience a slow progression towards sales adoption over the next few years.
However, increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals across the world are factors driving adoption of next generation optical biometry devices.
With advancements in technology, automated versions of next generation optical biometry devices have been developed aiding measurement of eyes before refractive and cataract surgeries. Such factors are expected to influence the market growth in upcoming years.
As per FMI, the global next generation optical biometry devices market was valued at USD 320.7 Mn in 2021.
Increasing incidence of eye diseases such as cataract and refractive errors coupled with rising number of eye care clinics and hospitals across the world are factors driving adoption of next generation optical biometry devices.
With advancements in technology, next generation optical biometry devices have been developed aiding measurement of eyes before refractive and cataract surgeries.
Next generation optical biometry devices are automated and measure various parameters such as axial length, anterior chamber depth, thickness of lens, retinal thickness, pupil size, and much more.
Next generation optical biometry devices are an accurate alternative for precise measurements and provide efficient results. Also, next generation optical biometry equipment avoid operator variations in measurements.
Rapid increase in the number of probe infections due to usage of ultrasound devices lead to post-operative errors, fueling demand for next generation optical biometry devices instead of ultrasound devices.
Manufacturers of next generation optical biometry devices are introducing automated instruments that are more efficient in measuring the segments of the eyes. Next generation optical biometry device suppliers are working on strengthening the related software to provide detailed information about the eye segments.
Companies manufacturing optical biometry devices are collaborating with local distributors/retailers to increase the product penetration of next generation optical biometry equipment.
Considering this, it is expected that the global next generation optical biometry devices market will rise at a CAGR of 5.4% over the forecast period.
The North American next generation optical biometry devices market is projected to account for 26.8% of the global market share in 2022.
According to the Prevent Blindness organization, 25 Mn Americans having cataract require medical care every year in the USA, thereby boosting demand for next generation optical biometry equipment in the region.
Rising acceptance of advanced optical biometry equipment, quick development of eye care infrastructure, and changing lifestyles are some of the factors that are predicted to contribute to next generation optical biometry devices market expansion in the region.
The USA government has increased its healthcare expenditure to approximately 7% by providing Medicare and Medicaid services - fueling availability of reimbUSAment for cataract surgeries. This is driving demand for advanced next generation optical biometry devices.
Patient safety is of topmost priority in the USA, which signals demand for faster and better ocular imaging. Emergence of optical devices, high potency and fastness of these devices, and growing number of hospitals are factors driving market growth of next generation optical biometry instruments and devices in the USA
Growing demand for next generation optical biometry devices is being noted in the UK due to rising number of cataract surgeries.
Growing use of next generation optical biometry devices for cataract surgeries in hospitals as well as progressive increase in the number of government and private hospitals in the UK are expected to boost demand growth of next generation optical biometry devices.
Increase in the number of cataract treatments performed and rising adoption of innovative practices for such procedures will also propel the market forward.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
In terms of revenue, swept-source optical coherent based biometry devices will account for significant revenue share in the next generation optical biometry devices industry over the forecast period. Swept-source optical coherent based biometry devices are set to exhibit highest revenue share in the next generation optical biometry devices market
Swept-source optical coherent based optical biometry devices are gaining popularity in the USA market. This category of next generation optical biometry devices is used especially at hospitals and ophthalmology clinics and specialized eye centers.
Some of the qualities driving demand for swept-source optical coherent based biometry devices include fast data capture, several measurements in a single process, enhanced wavelength, and the capacity to overcome ocular opacities.
The superiority of swept-source optical coherent based biometry devices over partial coherent interferometry is demonstrated by their ability to measure the axial length along six separate axes.
Hospitals account for 41.8% revenue share in next generation optical biometry device demand.
The market is predicted to grow as the number of private and government hospitals gradually increases. Growing use of next generation optical biometry devices in medical settings, such as hospitals, is expected to boost overall market expansion.
Medical services and vision benefits offered under Medicare include cataract surgeries, which will increase demand for next generation optical biometry devices over the coming years. Patients' increased trust in hospitals that are committed to providing all types of medical solutions will further fuel market growth.
COVID-19 posed significant challenges to the optical biometry devices market in recent months, pushing market participants to the limit. Companies are finding it harder to make informed judgments regarding their products, supply networks, and regulatory duties while the COVID-19 pandemic continues to unfold.
COVID-19 forced a lot of people to postpone medical treatment, which has the potential to have a significant influence on the healthcare industry. Manufacturers are figuring out how to recover from the current situation by reorganizing their sales channels and introducing new products. The global market for next generation optical biometry devices is likely to stabilize over the coming years.
The competition section of the next generation optical biometry devices industry report features the profiles of key players based on their market shares, differentiating strategies, product offerings, and marketing approach.
Key manufacturers of next generation optical biometry devices are focusing on novel marketing strategies to increase product penetration. Companies supplying next generation optical biometry products are concentrating on price floor strategies and offering lucrative discounts.
Attribute | Details |
---|---|
Forecast Period | 2022 to 2028 |
Historical Data Available for | 2013 to 2021 |
Market Analysis | Value in USD Million, Volume in Units |
Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia & Pacific; Middle East & Africa (MEA) |
Key Countries Covered | USA, Canada, Mexico, Brazil, Mexico, Argentina, Germany, Italy, France, UK, Nordic, Spain, Japan, China, India, Malaysia, Thailand, Australia, GCC Countries, South Africa, Turkey |
Key Market Segments Covered | Product Type, End User, Region |
Key Companies Profiled | Nidek Co Ltd.; Ziemer Ophthalmic Systems; TOMEY GmbH; Movu Inc.; OCULUS Optikgeräte GmbH.; Bausch & Lomb Incorporated; Topcon Corporation; Heine Optotechnik GmbH & Co. KG; AMETEK, Inc.; Optovue, Incorporated; Leica Microsystems GmbH |
Pricing | Available upon Request |
The next generation optical biometry devices market is anticipated to experience a CAGR of 5.4%, culminating in a market valuation of USD 461.3 million by 2028.
Challenges encompass high initial costs, data security concerns, privacy issues, and adapting to evolving reimbursement policies.
Fueled by the demand of 25 million people needing cataract care annually, North America leads the global next generation optical biometry devices market.
Swept-source optical coherence-based biometry devices secure significant revenue due to advanced imaging, better accuracy, and suitability for complex ocular conditions.
Rising eye disease prevalence, growing elderly population, accuracy-boosting tech advancements, and demand for minimally invasive surgeries drive product demand.
A recent key development in the market involves the introduction of portable handheld devices for telemedicine applications.
1. Executive Summary 2. Market Introduction 3. Market Opportunity Analysis 4. Global Economic Outlook 5. Market Background 6. Macroeconomic Assumptions 7. Key Inclusions 8. North America Market Analysis 2013 to 2021 and Forecast 2022 to 2028 9. Western Europe Market Analysis 2013 to 2021 and Forecast 2022 to 2028 10. Eastern Europe Market Analysis 2013 to 2021 and Forecast 2022 to 2028 11. Latin America Market Analysis 2013 to 2021 and Forecast 2022 to 2028 12. Asia Pacific Excluding China & Japan Market Analysis 2013 to 2021 and Forecast 2022 to 2028 13. Japan Market Analysis 2013 to 2021 and Forecast 2022 to 2028 14. Biometry Devices Market Analysis 2013 to 2021 and Forecast 2022 to 2028 15. Forecast Factors: Relevance and Impact 16. Forecast Assumptions 17. Market Structure Analysis 18. Competition Analysis 18.1. Carl Zeiss AG 18.2. Nidek Co Ltd 18.3. Haag-Streit AG 18.4. Ziemer Ophthalmic Systems 18.5. Optovue, Incorporated 18.6. Topcon Corporation 18.7. TOMEY GmbH 18.8. Movu Inc. 18.9. Newway Technology 19. Global Market Analysis 2013 to 2021 and Forecast 2022 to 2028 by Region 19.1. North America 19.2. Western Europe 19.3. Eastern Europe 19.4. Latin America 19.5. Asia Pacific 20. Market Analysis 2013 to 2021 and Forecast 2022 to 2028, By Product Type 20.1. Swept-source Optical Coherence Tomography (OCT) based Biometers 20.2. Partial coherence interferometry (PCI) based Biometers 20.3. Optical Low Coherence Reflectometry (OLCR) based Biometers 21. Market Analysis 2013 to 2021 and Forecast 2022 to 2028, By End User 21.1. Hospitals 21.2. Ophthalmology clinics and specialized eye care centers 21.3. Ambulatory Surgical centers 22. Market Analysis 2013 to 2021 and Forecast 2022 to 2028 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports